Comparative efficacy and acceptability of disease-modifying therapies in patients with relapsing–remitting multiple sclerosis: a systematic review and network meta-analysis

被引：0
|
作者：
Huihui Li
Fengli Hu
Yanli Zhang
Kai Li
机构：
[1] Heze Municipal Hospital,Department of Neurology
来源：
Journal of Neurology | 2020年 / 267卷
关键词：
Disease-modifying therapy; Relapsing–remitting multiple sclerosis; Systematic review; Network meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3489 / 3498
页数：9
相关论文
共 50 条
  • [1] Comparative efficacy and acceptability of disease-modifying therapies in patients with relapsing-remitting multiple sclerosis: a systematic review and network meta-analysis
    Li, Huihui
    Hu, Fengli
    Zhang, Yanli
    Li, Kai
    [J]. JOURNAL OF NEUROLOGY, 2020, 267 (12) : 3489 - 3498
  • [2] Comparative efficacy of disease-modifying therapies for patients with relapsing remitting multiple sclerosis: Systematic review and network meta-analysis
    Fogarty, Emer
    Schmitz, Susanne
    Tubridy, Niall
    Walsh, Cathal
    Barry, Michael
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 9 : 23 - 30
  • [3] Comparative efficacy and safety of disease-modifying therapies in patients with relapsing multiple sclerosis: A systematic review and network meta-analysis
    Chen, Chaoyang
    Zhang, Enyao
    Zhu, Chunsu
    Wei, Ran
    Ma, Lingyun
    Dong, Xiu
    Li, Ruoming
    Sun, Feng
    Zhou, Ying
    Cui, Yimin
    Liu, Zhenming
    [J]. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2023, 63 (01) : 8 - +
  • [4] Comparative safety of high-efficacy disease-modifying therapies in relapsing–remitting multiple sclerosis: a systematic review and network meta-analysis
    Katarzyna Śladowska
    Paweł Kawalec
    Przemysław Holko
    Oktawia Osiecka
    [J]. Neurological Sciences, 2022, 43 (9) : 5479 - 5500
  • [5] Disease-Modifying Therapies for Relapsing–Remitting Multiple Sclerosis: A Network Meta-Analysis
    Rosa C. Lucchetta
    Fernanda S. Tonin
    Helena H. L. Borba
    Letícia P. Leonart
    Vinicius L. Ferreira
    Aline F. Bonetti
    Bruno S. Riveros
    Jefferson Becker
    Roberto Pontarolo
    Fernando Fernandez-Llimós
    Astrid Wiens
    [J]. CNS Drugs, 2018, 32 : 813 - 826
  • [6] Comparative safety of high-efficacy disease-modifying therapies in relapsing-remitting multiple sclerosis: a systematic review and network meta-analysis
    Sladowska, Katarzyna
    Kawalec, Pawel
    Holko, Przemyslaw
    Osiecka, Oktawia
    [J]. NEUROLOGICAL SCIENCES, 2022, 43 (09) : 5479 - 5500
  • [7] Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: A Network Meta-Analysis
    Lucchetta, Rosa C.
    Tonin, Fernanda S.
    Borba, Helena H. L.
    Leonart, Leticia P.
    Ferreira, Vinicius L.
    Bonetti, Aline F.
    Riveros, Bruno S.
    Becker, Jefferson
    Pontarolo, Roberto
    Fernandez-Llimos, Fernando
    Wiens, Astrid
    [J]. CNS DRUGS, 2018, 32 (09) : 813 - 826
  • [8] Impact of disease-modifying therapies on MRI outcomes in patients with relapsing-remitting multiple sclerosis: A systematic review and network meta-analysis
    Bose, Debdipta
    Ravi, Renju
    Maurya, Miteshkumar
    Pushparajan, Libby
    Konwar, Mahanjit
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 61
  • [9] Disease modifying therapies in relapsing-remitting multiple sclerosis: A systematic review and network meta-analysis
    Liu, Zhuoyi
    Liao, Qiao
    Wen, Haicheng
    Zhang, Yihao
    [J]. AUTOIMMUNITY REVIEWS, 2021, 20 (06)
  • [10] Efficacy of disease-modifying therapies in relapsing remitting multiple sclerosis: A systematic comparison
    Freedman, Mark S.
    Hughes, Bruce
    Mikol, Daniel D.
    Bennett, Randy
    Cuffel, Brian
    Divan, Vamil
    LaVallee, Nicole
    Al-Sabbagh, Ahmad
    [J]. EUROPEAN NEUROLOGY, 2008, 60 (01) : 1 - 11
12345